Skip to Main Content

Author Details

Thais S Sabedot
2015
15
9
PMIDPaper TitleJournal TitlePublished Year
37329568Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas.Neuro Oncol2023
37704607Detection of diagnostic and prognostic methylation-based signatures in liquid biopsy specimens from patients with meningiomas.Nat Commun2023
35212383Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors.Neuro Oncol2022
33560371A serum-based DNA methylation assay provides accurate detection of glioma.Neuro Oncol2021
33914057Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma.Neuro Oncol2021
33631002DNA methylation-based signatures classify sporadic pituitary tumors according to clinicopathological features.Neuro Oncol2021
31665443Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomas.Neuro Oncol2020
30131588A non-functional galanin receptor-2 in a multiple sclerosis patient.Pharmacogenomics J2019
29361062RGBM: regularized gradient boosting machines for identification of the transcriptional regulators of discrete glioma subtypes.Nucleic Acids Res2018
29036500Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications.Neuro Oncol2018
29642018A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence.Cell Rep2018
29383100SIRT1 regulates Mxd1 during malignant melanoma progression.Oncotarget2017
26704973TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data.Nucleic Acids Res2016
26824661Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma.Cell2016
26061751Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.N Engl J Med2015
  • 1 - 15 of 15

Recommended Authors

Collaborators

Houtan Noushmehr
Henry Ford Hospital
Co-authored papers 15
Tathiane M Malta
School of Pharmaceutical Sciences of Ribeirao Preto, University of Sao Paulo
Co-authored papers 9
Laila M Poisson
Co-authored papers 7
Tom Mikkelsen
Ontario Brain Institute
Co-authored papers 6
Antonio Iavarone
Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami
Co-authored papers 5
Carlos Gilberto Carlotti
Co-authored papers 4
Daniela Pretti da Cunha Tirapelli
Co-authored papers 4
Jill S Barnholtz-Sloan
National Cancer Institute
Co-authored papers 4
Roel G W Verhaak
Yale School of Medicine
Co-authored papers 3
Sofie R Salama
Genomics Institute, University of California Santa Cruz
Co-authored papers 3
Mark Rosenblum
Henry Ford Hospital
Co-authored papers 3
Tiago C Silva
University of Miami Miller School of Medicine
Co-authored papers 3
Peter W Laird
Van Andel Institute
Co-authored papers 3
Olena Morozova
University of California Santa Cruz Genomics Institute
Co-authored papers 3
Michele Ceccarelli
Co-authored papers 3
Kenneth Aldape
National Cancer Institute
Co-authored papers 3
Matthew Meyerson
Broad Institute
Co-authored papers 2
Christel Herold-Mende
Co-authored papers 2
Amie Radenbaugh
Co-authored papers 2
Andreas von Deimling
Co-authored papers 2
David Haussler
Genomics Institute, University of California Santa Cruz
Co-authored papers 2
William A Friedman
Co-authored papers 2
Daniel J Brat
Co-authored papers 2
Siyuan Zheng
Greehey Children's Cancer Research Institute
Co-authored papers 2
Mia Grifford
Co-authored papers 2
Andrew E Sloan
Co-authored papers 2
Jean Claude Zenklusen
National Cancer Institute
Co-authored papers 2
Wai-Kwan Alfred Yung
University of Texas M.D. Anderson Cancer Center
Co-authored papers 2
Arvind Rao
University of Michigan-Ann Arbor
Co-authored papers 2
John Z Sanborn
Co-authored papers 2
Release 1.2